| Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds P Hou, Y Li, X Zhang, C Liu, J Guan, H Li, T Zhao, J Ye, W Yang, K Liu, ... Science 341 (6146), 651-654, 2013 | 1716 | 2013 |
| Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts H Liu, F Zhu, J Yong, P Zhang, P Hou, H Li, W Jiang, J Cai, M Liu, K Cui, ... Cell stem cell 3 (6), 587-590, 2008 | 666 | 2008 |
| Two supporting factors greatly improve the efficiency of human iPSC generation Y Zhao, X Yin, H Qin, F Zhu, H Liu, W Yang, Q Zhang, C Xiang, P Hou, ... Cell stem cell 3 (5), 475-479, 2008 | 640 | 2008 |
| Targeting YAP-dependent MDSC infiltration impairs tumor progression G Wang, X Lu, P Dey, P Deng, CC Wu, S Jiang, Z Fang, K Zhao, ... Cancer discovery 6 (1), 80-95, 2016 | 540 | 2016 |
| Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules Y Li, Q Zhang, X Yin, W Yang, Y Du, P Hou, J Ge, C Liu, W Zhang, ... Cell research 21 (1), 196-204, 2011 | 419 | 2011 |
| Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus A Zheng, F Yuan, Y Li, F Zhu, P Hou, J Li, X Song, M Ding, H Deng Journal of virology 81 (22), 12465-12471, 2007 | 301 | 2007 |
| Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer W Yao, JL Rose, W Wang, S Seth, H Jiang, A Taguchi, J Liu, L Yan, ... Nature 568 (7752), 410-414, 2019 | 180 | 2019 |
| Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer P Hou, A Kapoor, Q Zhang, J Li, CJ Wu, J Li, Z Lan, M Tang, X Ma, ... Cancer discovery 10 (7), 1058-1077, 2020 | 118 | 2020 |
| Targeting YAP-dependent MDSC infiltration impairs tumor progression. Cancer Discov. 2016; 6: 80–95. doi: 10.1158/2159-8290 G Wang, X Lu, P Dey, P Deng, CC Wu, S Jiang, Z Fang, K Zhao, ... CD-15-0224.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 89 | |
| USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation P Hou, X Ma, Q Zhang, CJ Wu, W Liao, J Li, H Wang, J Zhao, X Zhou, ... Genes & development 33 (19-20), 1361-1366, 2019 | 88 | 2019 |
| Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer P Gulhati, A Schalck, S Jiang, X Shang, CJ Wu, P Hou, SH Ruiz, LS Soto, ... Nature cancer 4 (1), 62-80, 2023 | 71 | 2023 |
| Telomere dysfunction activates YAP1 to drive tissue inflammation D Chakravarti, B Hu, X Mao, A Rashid, J Li, J Li, W Liao, EM Whitley, ... Nature communications 11 (1), 4766, 2020 | 71 | 2020 |
| Role of the tumor microenvironment in regulating pancreatic cancer therapy resistance D Deng, R Patel, CY Chiang, P Hou Cells 11 (19), 2952, 2022 | 31 | 2022 |
| P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis M Zhu, R Peng, X Liang, Z Lan, M Tang, P Hou, JH Song, CSL Mak, ... Oncogene 40 (41), 6049-6056, 2021 | 26 | 2021 |
| USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer P Hou, X Ma, Z Yang, Q Zhang, CJ Wu, J Li, L Tan, W Yao, L Yan, X Zhou, ... Genes & development 35 (19-20), 1327-1332, 2021 | 26 | 2021 |
| Conquering oncogenic KRAS and its bypass mechanisms P Hou, YA Wang Theranostics 12 (13), 5691, 2022 | 12 | 2022 |
| Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer. Cancer Discov. 2020; 10: 1058–1077. doi: 10.1158/2159-8290 P Hou, A Kapoor, Q Zhang, J Li, CJ Wu, J Li, Z Lan, M Tang, X Ma, ... CD-19-0597.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 12 | |
| Compositions and methods for reprograming non-pluripotent cells into pluripotent stem cells H Deng, Y Zhao, P Hou, Y Li, X Zhang, C Liu, J Guan, H Li US Patent 9,982,237, 2018 | 5 | 2018 |
| NFAT5 governs cellular plasticity-driven resistance to KRAS-targeted therapy in pancreatic cancer D Deng, H Begum, T Liu, J Zhang, Q Zhang, T Chu, H Li, A Lemenze, ... Journal of Experimental Medicine 221 (11), e20240766, 2024 | 1 | 2024 |
| Abstract C016: Pancreatitis-induced resistance to KRAS targeted therapy: The role of cellular plasticity and underlying mechanisms D Deng, P Hou Cancer Research 84 (17_Supplement_2), C016-C016, 2024 | | 2024 |